Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

1,274 total articles

GXO Expands Partnership with NHS England

GXO Expands Partnership with NHS England

GXO Logistics has been appointed by NHS England to continue managing the supply and distribution of Faecal Immunochemical Test (FIT) home testing kits as part of the national bowel cancer screening programme. This contract expands GXO's presence in healthcare logistics and supports NHS England's 10 Year Health Plan for community-based care and earl…

Red Cat Announces Strategic Partnership with Ukraine’s Spetstechnoexport to Advance Multi-Domain Uncrewed Systems Collaboration

Red Cat Announces Strategic Partnership with Ukraine’s Spetstechnoexport to Advance Multi-Domain Uncrewed Systems Collaboration

Red Cat Holdings, Inc., a U.S.-based defense technology firm, announced a strategic partnership with Ukraine's state-owned defense enterprise Spetstechnoexport (STE) to accelerate development and deployment of advanced unmanned aerial, land, and maritime systems. The partnership aims to integrate technologies, expand production, and facilitate glob…

Verizon to report earnings April 27, 2026

Verizon to report earnings April 27, 2026

Verizon Communications Inc. will report its first-quarter 2026 earnings on April 27, 2026. The company will host a webcast to present its financial results, with detailed materials available on its Investor Relations website ahead of the event.

iQIYI Announces Latest Corporate and Business Developments

iQIYI Announces Latest Corporate and Business Developments

iQIYI, a leading Chinese online entertainment video provider listed on Nasdaq, announced plans for a proposed listing on the Hong Kong Stock Exchange to expand capital access and investor base in Asia. The company also approved a $100 million share repurchase program to demonstrate confidence in its long-term prospects. Additionally, iQIYI launched…

LT350 Releases Whitepaper Detailing Distributed, Power-Sovereign AI Infrastructure for the Inference Economy

LT350 Releases Whitepaper Detailing Distributed, Power-Sovereign AI Infrastructure for the Inference Economy

Auddia Inc. announced that LT350, a business unit soon to be merged under the McCarthy Finney holding company via Auddia's pending deal with Thramann Holdings, published a whitepaper introducing a novel distributed AI data center architecture. LT350's platform utilizes modular solar-powered canopies installed on existing parking lots to create powe…

Compass Diversified Announces Definitive Agreement to Sell Sterno’s Food Service Business for $292.5 Million and Accelerate Deleveraging

Compass Diversified Announces Definitive Agreement to Sell Sterno’s Food Service Business for $292.5 Million and Accelerate Deleveraging

Compass Diversified (NYSE: CODI) announced a definitive agreement to sell the food service business of its subsidiary Sterno to Archer Foodservice Partners for $292.5 million. The sale enables CODI to repay debt and reduce its senior secured net leverage ratio to below 1.0x, improving financial flexibility. Post-sale, CODI will retain the Sterno ho…

Equinox Gold Updates Canadian Operations Technical Outlook: Average 540,000 Ounces Gold Production per Year for Next 10 Years

Equinox Gold Updates Canadian Operations Technical Outlook: Average 540,000 Ounces Gold Production per Year for Next 10 Years

Equinox Gold Corp. has updated its technical outlook for its Canadian operations, forecasting an average annual gold production of approximately 540,000 ounces over the next 10 years. Key drivers include reaching full milling capacity at the Greenstone Gold Mine with an average production of 320,000 ounces per year, and the Phase 2 expansion at the…

Sysco to Acquire Jetro Restaurant Depot to Expand into Higher-Margin, Growing, and Resilient Cash & Carry Channel

Sysco to Acquire Jetro Restaurant Depot to Expand into Higher-Margin, Growing, and Resilient Cash & Carry Channel

Sysco Corporation is acquiring Jetro Restaurant Depot in a transformative $29.1 billion transaction. The acquisition expands Sysco's presence into the growing, higher-margin cash & carry segment serving smaller independent restaurants. The deal is expected to be immediately accretive to earnings, deliver significant synergies, and create growth opp…

SEGG Media Aligns Leadership to Drive Revenue Execution and Growth

SEGG Media Aligns Leadership to Drive Revenue Execution and Growth

Sports Entertainment Gaming Global Corporation (SEGG Media) announced the appointment of key executives from Veloce to strengthen its leadership team, emphasizing a strategic growth phase focused on revenue execution, operational integration, and monetization of digital media assets. The company aims to expand revenue streams through its global spo…

Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Neumora Therapeutics announced their Q4 and full-year 2025 financial results alongside key clinical progress updates. Highlights include positive Phase 1b data reinforcing NMRA-511's potential in Alzheimer's disease agitation, full enrollment of KOASTAL-2 and -3 studies with expected data readout in Q2 2026, advancement of NMRA-898 for schizophreni…

Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent

Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent

Sight Sciences announced that the U.S. District Court for the District of Delaware upheld a jury verdict finding Alcon willfully infringed three of Sight Sciences' patents related to glaucoma treatment devices. The Court awarded Sight Sciences $34 million in past damages plus supplemental damages and interest, and granted an ongoing 10% royalty on …

PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024

PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024

PMGC Holdings Inc. (NASDAQ: ELAB) filed its 2025 Annual Report highlighting a 43% growth in total assets to $12.87 million, driven by three strategic acquisitions in precision manufacturing and specialty IT hardware packaging serving aerospace, defense, and semiconductor sectors. The company also advanced its biopharmaceutical subsidiary, Northstri…

Connect Biopharma Announces $20.2 Million Private Placement Financing

Connect Biopharma Announces $20.2 Million Private Placement Financing

Connect Biopharma announced a $20.2 million private placement financing led by existing investor Panacea Venture, extending its cash runway through the second half of 2027. The funds will support the development of its clinical-stage drug candidates targeting inflammatory diseases such as asthma and COPD, particularly the next-generation antibody r…

Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

Aquestive Therapeutics announced successful completion of a Type A meeting with the FDA regarding the resubmission of the New Drug Application (NDA) for Anaphylm (dibutepinephrine) sublingual film, reaffirming plans to resubmit in Q3 2026. The FDA provided clarifying feedback on pharmacokinetic and human factor study designs, and the company is pre…

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

PDS Biotechnology Corporation reported financial results for 2025 and updated on clinical progress, including a Phase 3 trial amendment for PDS0101 that incorporates progression-free survival as an interim primary endpoint, potentially shortening trial duration and costs while preserving overall survival as the full approval endpoint. Early promisi…